The Bayer-Monsanto deal: one of the worst corporate deals ever

• Autor(a) principal: Ongun, Aylin
• Data de Publicação: 2020
• Tipo de documento: Dissertação
• Idioma: eng
• Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
• Texto Completo: http://hdl.handle.net/10362/145300
• topic: Mergers and acquisitions; Corporate finance; Synergies; Corporate governance; Stakeholder activism; Domínio/Área Científica::Ciências Sociais::Economia e Gestão

This case describes the long-lasting acquisition process of Monsanto by the Germany-based multinational company Bayer, that was closed in June 2018. Given the rising skepticism and resistance regarding the deal on the part of both Bayer’s stakeholders and shareholders, the case will particularly focus on the rationale of the transaction and the motivation of the management board to keep their commitment to the acquisition while reflecting on the Corporate Governance of Bayer as well. Apart from the strategic reasons, the case also addresses the issues that arose in the course of the process and discusses whether the exceptionally high acquisition premium is justified or not.